Order of September 28, 2023 establishing the list of substances presenting endocrine disrupting properties mentioned in I and II of article L. 5232-5 of the public health code and the categories of products presenting a particular risk of exposure mentioned in II of article L. 5232-5 of the public health code. The purpose of this regulation is to ensure that the presence of endocrine disrupting substances (EDCs) in products is more transparent to the public. The annex to the regulation provides a list of endocrine disruptors.
- Substances with proven and presumed endocrine-disrupting properties, mentioned in I of article L. 5232-5 of the French Public Health Code, are listed in tables A and A bis in appendix I of the present order.
- Substances with suspected endocrine-disrupting properties, mentioned in II of article L. 5232-5 of the French Public Health Code, are listed in tables B and B bis in appendix I of the present order.
